Italy

 

Covid continues to boost Unilabs in 2021

Executive chairman Jos Lamers has told HBI that Covid sales continue to rise in Q1 and Q2 2021. They certainly boosted 2020 results at the international lab and imaging group owned by Apax Partners. Like rivals Synlab and Sonic, the business continues to roar away. 

EQT buys Partners’ stake in Cerba

EQT has agreed to buy Partners Group's stake in French lab group Cerba for a ball-park enterprise value of €4.5bn, making it a 12x multiple on the group's 2020 EBITDA.

Lifebrain for sale as EBITDA for lab groups near doubles

Italian lab group Lifebrain is the latest to take advantage of swollen revenues and profits in the lab sector with owner Investindustrial appointing Goldman Sachs and JP Morgan to explore a sale. Meanwhile, COVID-19 testing across Europe led to a near doubling of EBITDA for the largest players in the third quarter of 2020.

Garofalo continues M&A as Covid hits 2020 organic growth

Listed Italian hospital, post-acute and outpatient group Garofalo Healthcare (GHC) has continued its M&A drive with the acquisition of a hospital in Verona for 8.5x 2019 EBITDA. Deal-making drove 7.3% revenue growth in 2020 to €196.5m, although on a like-for-like basis, revenues fell 5.2%. That is still much better than many large Italian hospital groups.

Interview: Mark Chapman, International CEO, Life Healthcare

What are South African hospital group Life Healthcare's plans for its international division, mainly comprised of pan-European imaging operator Alliance Medical? In a long and wide-ranging discussion, Chapman talks about expansion in South Africa and one to two new countries, 'winners and losers' in the imaging AI market, tariff pressure across Europe and what the first new potential drug therapy for Alzheimer's in 18 years means for its PET-CT business.

Italy’s recovery plan has €18bn for healthcare, the UK’s none

Italy's COVID-19 recovery plan contains €18bn for homecare, integrated health facilities and telemedicine that can be run by the private sector in a whole-scale reform of the country's healthcare system. Meanwhile, a new budget in the UK failed to allot any new funds for its overstretched health and social service. 

Find Us